nodes	percent_of_prediction	percent_of_DWPC	metapath
Fentanyl—OPRD1—forebrain—endogenous depression	0.0296	0.0873	CbGeAlD
Fentanyl—Loperamide—POMC—endogenous depression	0.0291	0.205	CrCbGaD
Fentanyl—OPRK1—forebrain—endogenous depression	0.0284	0.0837	CbGeAlD
Fentanyl—Alverine—HTR1A—endogenous depression	0.0247	0.174	CrCbGaD
Fentanyl—CYP3A4—Farnesoid X Receptor  Pathway—FKBP5—endogenous depression	0.0219	0.0422	CbGpPWpGaD
Fentanyl—ABCB1—Codeine and Morphine Metabolism—CYP2D6—endogenous depression	0.021	0.0405	CbGpPWpGaD
Fentanyl—OPRM1—brainstem—endogenous depression	0.0209	0.0617	CbGeAlD
Fentanyl—OPRM1—forebrain—endogenous depression	0.0202	0.0595	CbGeAlD
Fentanyl—CYP3A7—Xenobiotics—CYP2D6—endogenous depression	0.0185	0.0356	CbGpPWpGaD
Fentanyl—CYP3A7—endocrine gland—endogenous depression	0.0181	0.0532	CbGeAlD
Fentanyl—Bepridil—CACNA1C—endogenous depression	0.0176	0.124	CrCbGaD
Fentanyl—OPRD1—nervous system—endogenous depression	0.0161	0.0474	CbGeAlD
Fentanyl—OPRD1—central nervous system—endogenous depression	0.0155	0.0456	CbGeAlD
Fentanyl—OPRK1—nervous system—endogenous depression	0.0154	0.0454	CbGeAlD
Fentanyl—OPRK1—central nervous system—endogenous depression	0.0148	0.0437	CbGeAlD
Fentanyl—OPRK1—cerebellum—endogenous depression	0.0145	0.0427	CbGeAlD
Fentanyl—CYP3A5—Xenobiotics—CYP2D6—endogenous depression	0.0134	0.0258	CbGpPWpGaD
Fentanyl—OPRM1—midbrain—endogenous depression	0.0133	0.0393	CbGeAlD
Fentanyl—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—endogenous depression	0.0129	0.0249	CbGpPWpGaD
Fentanyl—CYP3A5—Tamoxifen metabolism—CYP2D6—endogenous depression	0.0128	0.0248	CbGpPWpGaD
Fentanyl—OPRD1—brain—endogenous depression	0.0123	0.0362	CbGeAlD
Fentanyl—OPRK1—brain—endogenous depression	0.0118	0.0347	CbGeAlD
Fentanyl—OPRM1—endocrine gland—endogenous depression	0.0117	0.0345	CbGeAlD
Fentanyl—OPRM1—nervous system—endogenous depression	0.011	0.0323	CbGeAlD
Fentanyl—Astemizole—CYP2D6—endogenous depression	0.0107	0.0754	CrCbGaD
Fentanyl—OPRM1—central nervous system—endogenous depression	0.0106	0.0311	CbGeAlD
Fentanyl—OPRK1—Mecp2 and Associated Rett Syndrome—BDNF—endogenous depression	0.00916	0.0177	CbGpPWpGaD
Fentanyl—Aprindine—CYP2D6—endogenous depression	0.00887	0.0625	CrCbGaD
Fentanyl—OPRM1—brain—endogenous depression	0.00839	0.0247	CbGeAlD
Fentanyl—OPRM1—G-protein activation—POMC—endogenous depression	0.00828	0.016	CbGpPWpGaD
Fentanyl—Darifenacin—CYP2D6—endogenous depression	0.00785	0.0552	CrCbGaD
Fentanyl—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.00767	0.0148	CbGpPWpGaD
Fentanyl—Fexofenadine—CYP2D6—endogenous depression	0.00763	0.0537	CrCbGaD
Fentanyl—CYP3A7—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.00757	0.0146	CbGpPWpGaD
Fentanyl—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—endogenous depression	0.00742	0.0143	CbGpPWpGaD
Fentanyl—Benzatropine—CYP2D6—endogenous depression	0.00696	0.049	CrCbGaD
Fentanyl—OPRM1—TCR Signaling Pathway—GATA3—endogenous depression	0.00645	0.0124	CbGpPWpGaD
Fentanyl—CYP3A5—endocrine gland—endogenous depression	0.00636	0.0187	CbGeAlD
Fentanyl—CYP3A7—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.00622	0.012	CbGpPWpGaD
Fentanyl—CYP3A4—Xenobiotics—CYP2D6—endogenous depression	0.00621	0.012	CbGpPWpGaD
Fentanyl—Propafenone—CYP2D6—endogenous depression	0.00615	0.0433	CrCbGaD
Fentanyl—OPRM1—IL4-mediated signaling events—IL10—endogenous depression	0.00602	0.0116	CbGpPWpGaD
Fentanyl—CYP3A4—Tamoxifen metabolism—CYP2D6—endogenous depression	0.00597	0.0115	CbGpPWpGaD
Fentanyl—ABCB1—forebrain—endogenous depression	0.00583	0.0172	CbGeAlD
Fentanyl—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.00555	0.0107	CbGpPWpGaD
Fentanyl—Bepridil—CYP2D6—endogenous depression	0.00548	0.0386	CrCbGaD
Fentanyl—CYP3A5—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.00547	0.0106	CbGpPWpGaD
Fentanyl—ABCB1—adrenal cortex—endogenous depression	0.0054	0.0159	CbGeAlD
Fentanyl—CYP3A4—Tryptophan metabolism—TPH1—endogenous depression	0.00526	0.0102	CbGpPWpGaD
Fentanyl—OPRD1—Peptide ligand-binding receptors—OXT—endogenous depression	0.00515	0.00993	CbGpPWpGaD
Fentanyl—CYP3A4—Estrogen metabolism—COMT—endogenous depression	0.00512	0.00988	CbGpPWpGaD
Fentanyl—Dextropropoxyphene—CYP2D6—endogenous depression	0.0051	0.0359	CrCbGaD
Fentanyl—ABCB1—HIF-1-alpha transcription factor network—ADM—endogenous depression	0.00498	0.0096	CbGpPWpGaD
Fentanyl—ABCB1—cardiovascular system—endogenous depression	0.00493	0.0145	CbGeAlD
Fentanyl—Loperamide—CYP2D6—endogenous depression	0.00486	0.0342	CrCbGaD
Fentanyl—CYP3A4—endocrine gland—endogenous depression	0.00478	0.0141	CbGeAlD
Fentanyl—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.00468	0.00903	CbGpPWpGaD
Fentanyl—OPRK1—Peptide ligand-binding receptors—OXT—endogenous depression	0.00451	0.00871	CbGpPWpGaD
Fentanyl—CYP3A5—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.0045	0.00867	CbGpPWpGaD
Fentanyl—CYP3A4—nervous system—endogenous depression	0.00447	0.0132	CbGeAlD
Fentanyl—ABCB1—pituitary gland—endogenous depression	0.00436	0.0128	CbGeAlD
Fentanyl—CYP3A4—central nervous system—endogenous depression	0.0043	0.0127	CbGeAlD
Fentanyl—OPRD1—G alpha (i) signalling events—HTR1A—endogenous depression	0.00418	0.00807	CbGpPWpGaD
Fentanyl—ABCB1—adrenal gland—endogenous depression	0.0039	0.0115	CbGeAlD
Fentanyl—OPRD1—GPCRs, Class A Rhodopsin-like—HTR1A—endogenous depression	0.00388	0.00749	CbGpPWpGaD
Fentanyl—ABCB1—midbrain—endogenous depression	0.00385	0.0113	CbGeAlD
Fentanyl—OPRM1—Peptide ligand-binding receptors—OXT—endogenous depression	0.00382	0.00736	CbGpPWpGaD
Fentanyl—ABCB1—thyroid gland—endogenous depression	0.00376	0.0111	CbGeAlD
Fentanyl—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.00376	0.00725	CbGpPWpGaD
Fentanyl—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2C—endogenous depression	0.00375	0.00723	CbGpPWpGaD
Fentanyl—OPRK1—G alpha (i) signalling events—HTR1A—endogenous depression	0.00367	0.00707	CbGpPWpGaD
Fentanyl—Diphenhydramine—CYP2D6—endogenous depression	0.00358	0.0252	CrCbGaD
Fentanyl—Methadone—CYP2D6—endogenous depression	0.00346	0.0243	CrCbGaD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—OXT—endogenous depression	0.00345	0.00666	CbGpPWpGaD
Fentanyl—OPRM1—Opioid Signalling—POMC—endogenous depression	0.00344	0.00663	CbGpPWpGaD
Fentanyl—OPRK1—GPCRs, Class A Rhodopsin-like—HTR1A—endogenous depression	0.0034	0.00656	CbGpPWpGaD
Fentanyl—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.00338	0.00653	CbGpPWpGaD
Fentanyl—ABCB1—endocrine gland—endogenous depression	0.00338	0.00995	CbGeAlD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR1A—endogenous depression	0.00332	0.00641	CbGpPWpGaD
Fentanyl—CYP3A7—Biological oxidations—CYP2D6—endogenous depression	0.0033	0.00637	CbGpPWpGaD
Fentanyl—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2C—endogenous depression	0.00329	0.00634	CbGpPWpGaD
Fentanyl—OPRD1—GPCRs, Class A Rhodopsin-like—HTR7—endogenous depression	0.00328	0.00633	CbGpPWpGaD
Fentanyl—CYP3A7—Metapathway biotransformation—CYP2D6—endogenous depression	0.00326	0.00629	CbGpPWpGaD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2C—endogenous depression	0.00321	0.00619	CbGpPWpGaD
Fentanyl—ABCB1—nervous system—endogenous depression	0.00316	0.00932	CbGeAlD
Fentanyl—OPRD1—GPCR ligand binding—ADM—endogenous depression	0.00314	0.00605	CbGpPWpGaD
Fentanyl—OPRM1—G alpha (i) signalling events—HTR1A—endogenous depression	0.0031	0.00598	CbGpPWpGaD
Fentanyl—CYP3A7—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.00305	0.00588	CbGpPWpGaD
Fentanyl—ABCB1—central nervous system—endogenous depression	0.00305	0.00897	CbGeAlD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—OXT—endogenous depression	0.00303	0.00584	CbGpPWpGaD
Fentanyl—ABCB1—cerebellum—endogenous depression	0.00298	0.00877	CbGeAlD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR1A—endogenous depression	0.00291	0.00562	CbGpPWpGaD
Fentanyl—OPRK1—GPCRs, Class A Rhodopsin-like—HTR7—endogenous depression	0.00288	0.00555	CbGpPWpGaD
Fentanyl—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1A—endogenous depression	0.00288	0.00555	CbGpPWpGaD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2C—endogenous depression	0.00282	0.00543	CbGpPWpGaD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	0.00281	0.00543	CbGpPWpGaD
Fentanyl—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2C—endogenous depression	0.00278	0.00536	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—ADM—endogenous depression	0.00275	0.00531	CbGpPWpGaD
Fentanyl—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.00272	0.00524	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—CRH—endogenous depression	0.00263	0.00507	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—OXT—endogenous depression	0.00263	0.00507	CbGpPWpGaD
Fentanyl—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.00258	0.00497	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—OXT—endogenous depression	0.00256	0.00494	CbGpPWpGaD
Fentanyl—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.00254	0.00491	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—HTR1A—endogenous depression	0.00253	0.00488	CbGpPWpGaD
Fentanyl—CYP3A7—Biological oxidations—COMT—endogenous depression	0.0025	0.00483	CbGpPWpGaD
Fentanyl—CYP3A7—Biological oxidations—MAOA—endogenous depression	0.00249	0.0048	CbGpPWpGaD
Fentanyl—CYP3A7—Metapathway biotransformation—COMT—endogenous depression	0.00247	0.00476	CbGpPWpGaD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	0.00247	0.00476	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1A—endogenous depression	0.00246	0.00475	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—HTR2C—endogenous depression	0.00244	0.00472	CbGpPWpGaD
Fentanyl—OPRM1—GPCRs, Class A Rhodopsin-like—HTR7—endogenous depression	0.00243	0.00469	CbGpPWpGaD
Fentanyl—ABCB1—brain—endogenous depression	0.00242	0.00712	CbGeAlD
Fentanyl—CYP3A5—Biological oxidations—CYP2D6—endogenous depression	0.00239	0.00461	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2C—endogenous depression	0.00238	0.00459	CbGpPWpGaD
Fentanyl—CYP3A5—Metapathway biotransformation—CYP2D6—endogenous depression	0.00236	0.00454	CbGpPWpGaD
Fentanyl—OPRD1—Peptide ligand-binding receptors—POMC—endogenous depression	0.00234	0.00452	CbGpPWpGaD
Fentanyl—ABCB1—Allograft Rejection—IL10—endogenous depression	0.00233	0.00449	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—ADM—endogenous depression	0.00233	0.00449	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—CRH—endogenous depression	0.00231	0.00445	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—OXT—endogenous depression	0.00231	0.00445	CbGpPWpGaD
Fentanyl—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	0.0023	0.00443	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—HTR1A—endogenous depression	0.00222	0.00428	CbGpPWpGaD
Fentanyl—CYP3A5—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.0022	0.00425	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—HTR2C—endogenous depression	0.00214	0.00414	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—HTR7—endogenous depression	0.00214	0.00413	CbGpPWpGaD
Fentanyl—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.00209	0.00403	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	0.00208	0.00402	CbGpPWpGaD
Fentanyl—OPRK1—Peptide ligand-binding receptors—POMC—endogenous depression	0.00206	0.00397	CbGpPWpGaD
Fentanyl—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	0.00202	0.00389	CbGpPWpGaD
Fentanyl—OPRD1—G alpha (i) signalling events—POMC—endogenous depression	0.00198	0.00382	CbGpPWpGaD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	0.00197	0.0038	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—CRH—endogenous depression	0.00195	0.00376	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—OXT—endogenous depression	0.00195	0.00376	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—HTR7—endogenous depression	0.00188	0.00362	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—HTR1A—endogenous depression	0.00188	0.00362	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—HTR2C—endogenous depression	0.00181	0.0035	CbGpPWpGaD
Fentanyl—CYP3A5—Biological oxidations—COMT—endogenous depression	0.00181	0.00349	CbGpPWpGaD
Fentanyl—CYP3A5—Biological oxidations—MAOA—endogenous depression	0.0018	0.00347	CbGpPWpGaD
Fentanyl—CYP3A5—Metapathway biotransformation—COMT—endogenous depression	0.00178	0.00344	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—ADM—endogenous depression	0.00177	0.00342	CbGpPWpGaD
Fentanyl—OPRM1—Peptide ligand-binding receptors—POMC—endogenous depression	0.00174	0.00335	CbGpPWpGaD
Fentanyl—OPRK1—G alpha (i) signalling events—POMC—endogenous depression	0.00173	0.00335	CbGpPWpGaD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	0.00173	0.00333	CbGpPWpGaD
Fentanyl—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	0.0017	0.00329	CbGpPWpGaD
Fentanyl—CYP3A7—Biological oxidations—POMC—endogenous depression	0.00162	0.00312	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—ADM—endogenous depression	0.00161	0.00311	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—HTR7—endogenous depression	0.00159	0.00306	CbGpPWpGaD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	0.00157	0.00303	CbGpPWpGaD
Fentanyl—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.00157	0.00303	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—ADM—endogenous depression	0.00156	0.003	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—HTR2A—endogenous depression	0.0015	0.00289	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—OXT—endogenous depression	0.00149	0.00287	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—CRH—endogenous depression	0.00149	0.00287	CbGpPWpGaD
Fentanyl—OPRM1—G alpha (i) signalling events—POMC—endogenous depression	0.00147	0.00283	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	0.00146	0.00282	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—HTR1A—endogenous depression	0.00143	0.00276	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—ADM—endogenous depression	0.00141	0.00272	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—HTR2C—endogenous depression	0.00138	0.00267	CbGpPWpGaD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	0.00138	0.00266	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—CRH—endogenous depression	0.00135	0.0026	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—OXT—endogenous depression	0.00135	0.0026	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—HTR2A—endogenous depression	0.00132	0.00254	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—ADM—endogenous depression	0.00131	0.00254	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—CRH—endogenous depression	0.0013	0.00251	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—OXT—endogenous depression	0.0013	0.00251	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—HTR1A—endogenous depression	0.0013	0.00251	CbGpPWpGaD
Fentanyl—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.00126	0.00244	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—HTR2C—endogenous depression	0.00125	0.00242	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—HTR1A—endogenous depression	0.00125	0.00242	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—HTR2C—endogenous depression	0.00121	0.00234	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—HTR7—endogenous depression	0.00121	0.00233	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—endogenous depression	0.0012	0.00232	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—POMC—endogenous depression	0.0012	0.00231	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—ADM—endogenous depression	0.00119	0.0023	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—OXT—endogenous depression	0.00118	0.00228	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—CRH—endogenous depression	0.00118	0.00228	CbGpPWpGaD
Fentanyl—CYP3A5—Biological oxidations—POMC—endogenous depression	0.00117	0.00226	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	0.00117	0.00225	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—HTR1A—endogenous depression	0.00114	0.0022	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—HTR2A—endogenous depression	0.00111	0.00214	CbGpPWpGaD
Fentanyl—CYP3A4—Biological oxidations—CYP2D6—endogenous depression	0.00111	0.00214	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—OXT—endogenous depression	0.0011	0.00212	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—CRH—endogenous depression	0.0011	0.00212	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—HTR2C—endogenous depression	0.0011	0.00212	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—HTR7—endogenous depression	0.0011	0.00212	CbGpPWpGaD
Fentanyl—CYP3A4—Metapathway biotransformation—CYP2D6—endogenous depression	0.00109	0.00211	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—HTR7—endogenous depression	0.00106	0.00205	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—HTR1A—endogenous depression	0.00106	0.00205	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—POMC—endogenous depression	0.00105	0.00203	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—WASF2—endogenous depression	0.00104	0.00201	CbGpPWpGaD
Fentanyl—CYP3A4—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.00102	0.00198	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—HTR2C—endogenous depression	0.00102	0.00198	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—OXT—endogenous depression	0.001	0.00193	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CRH—endogenous depression	0.001	0.00193	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—WASF1—endogenous depression	0.000997	0.00192	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—HTR7—endogenous depression	0.000964	0.00186	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—HTR1A—endogenous depression	0.000963	0.00186	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—ADM—endogenous depression	0.000951	0.00184	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—TPH1—endogenous depression	0.000932	0.0018	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—HTR2C—endogenous depression	0.00093	0.00179	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—WASF2—endogenous depression	0.000912	0.00176	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—HTR7—endogenous depression	0.000897	0.00173	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—POMC—endogenous depression	0.000888	0.00171	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—WASF1—endogenous depression	0.000874	0.00169	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—HTR2A—endogenous depression	0.000848	0.00164	CbGpPWpGaD
Fentanyl—CYP3A4—Biological oxidations—COMT—endogenous depression	0.000841	0.00162	CbGpPWpGaD
Fentanyl—CYP3A4—Biological oxidations—MAOA—endogenous depression	0.000835	0.00161	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—ADM—endogenous depression	0.000834	0.00161	CbGpPWpGaD
Fentanyl—CYP3A4—Metapathway biotransformation—COMT—endogenous depression	0.00083	0.0016	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—HTR7—endogenous depression	0.000814	0.00157	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CRH—endogenous depression	0.000797	0.00154	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—OXT—endogenous depression	0.000797	0.00154	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—WASF2—endogenous depression	0.000771	0.00149	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—HTR2A—endogenous depression	0.00077	0.00148	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—HTR1A—endogenous depression	0.000767	0.00148	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—HTR2A—endogenous depression	0.000743	0.00143	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—HTR2C—endogenous depression	0.000741	0.00143	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—WASF1—endogenous depression	0.000739	0.00143	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—TPH2—endogenous depression	0.000707	0.00136	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CACNB2—endogenous depression	0.000707	0.00136	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ADM—endogenous depression	0.000705	0.00136	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CRH—endogenous depression	0.000699	0.00135	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—OXT—endogenous depression	0.000699	0.00135	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—DPYD—endogenous depression	0.000695	0.00134	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—POMC—endogenous depression	0.000677	0.00131	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—HTR2A—endogenous depression	0.000675	0.0013	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—TPH1—endogenous depression	0.000674	0.0013	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—HTR1A—endogenous depression	0.000673	0.0013	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—HTR2C—endogenous depression	0.00065	0.00125	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—HTR7—endogenous depression	0.000649	0.00125	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CACNA1C—endogenous depression	0.000646	0.00125	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—HTR2A—endogenous depression	0.000628	0.00121	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—POMC—endogenous depression	0.000615	0.00119	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—POMC—endogenous depression	0.000594	0.00115	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CRH—endogenous depression	0.000591	0.00114	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—OXT—endogenous depression	0.000591	0.00114	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—HTR2A—endogenous depression	0.00057	0.0011	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—HTR7—endogenous depression	0.000569	0.0011	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—HTR1A—endogenous depression	0.000569	0.0011	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CYP2D6—endogenous depression	0.000565	0.00109	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—HTR2C—endogenous depression	0.000549	0.00106	CbGpPWpGaD
Fentanyl—CYP3A4—Biological oxidations—POMC—endogenous depression	0.000544	0.00105	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—POMC—endogenous depression	0.000539	0.00104	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—TPH2—endogenous depression	0.000511	0.000986	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CACNB2—endogenous depression	0.000511	0.000986	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—TPH1—endogenous depression	0.000509	0.000981	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—DPYD—endogenous depression	0.000503	0.00097	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—POMC—endogenous depression	0.000502	0.000968	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—HTR7—endogenous depression	0.000481	0.000928	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CACNA1C—endogenous depression	0.000467	0.000901	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—POMC—endogenous depression	0.000456	0.000879	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—HTR2A—endogenous depression	0.000455	0.000877	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—COMT—endogenous depression	0.000428	0.000826	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—MAOA—endogenous depression	0.000425	0.00082	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CYP2D6—endogenous depression	0.000408	0.000788	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—HTR2A—endogenous depression	0.000399	0.000769	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CACNB2—endogenous depression	0.000385	0.000744	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—TPH2—endogenous depression	0.000385	0.000744	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—DPYD—endogenous depression	0.000379	0.000732	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—POMC—endogenous depression	0.000363	0.000701	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CACNA1C—endogenous depression	0.000353	0.00068	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—HTR2A—endogenous depression	0.000337	0.00065	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—POMC—endogenous depression	0.000318	0.000614	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—TPH1—endogenous depression	0.000313	0.000605	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—COMT—endogenous depression	0.000309	0.000597	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYP2D6—endogenous depression	0.000308	0.000595	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—MAOA—endogenous depression	0.000307	0.000593	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—POMC—endogenous depression	0.000277	0.000534	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—POMC—endogenous depression	0.000269	0.000519	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—TPH2—endogenous depression	0.000237	0.000458	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CACNB2—endogenous depression	0.000237	0.000458	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—DPYD—endogenous depression	0.000234	0.000451	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—COMT—endogenous depression	0.000234	0.000451	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—MAOA—endogenous depression	0.000232	0.000447	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CACNA1C—endogenous depression	0.000217	0.000419	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—POMC—endogenous depression	0.0002	0.000386	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP2D6—endogenous depression	0.00019	0.000366	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—POMC—endogenous depression	0.000151	0.000291	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—COMT—endogenous depression	0.000144	0.000278	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—MAOA—endogenous depression	0.000143	0.000276	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—POMC—endogenous depression	9.3e-05	0.000179	CbGpPWpGaD
